Literature DB >> 9063667

Synergistic effect of azithromycin on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leukocytes.

I Herrera-Insúa1, P Pérez, C Ramos, P Martínez, M L Gómez-Lus, J Prieto.   

Abstract

Many macrolides have been shown to affect the interaction between bacteria and various immune defense mechanisms, such as chemotaxis, accumulation, and bioactivity within phagocytic cells. The interaction of azithromycin with human polymorphonuclear leukocytes (PMNs) was studied in vitro and compared with the interactions between other macrolides and PMNs. The opsonophagocytic killing of Staphylococcus aureus was synergistically enhanced by azithromycin at concentrations below and above the minimal inhibitory concentration, with a reduction of up to 2.82 log10 cfu/ml with 2 mg/ml of azithromycin. Other macrolides were effective only at subinhibitory concentrations. The beneficial azithromycin-leukocyte interaction may explain azithromycin's efficacy against intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063667     DOI: 10.1007/bf01575113

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Failure of water to lyse polymorphonuclear neutrophils completely. Role of pH and implications for assessment of bacterial killing.

Authors:  R A Gargan; W Brumfitt; J M Hamilton-Miller
Journal:  J Immunol Methods       Date:  1989-11-30       Impact factor: 2.303

2.  [Effect of miocamycin and erythromycin on the activity of human neutrophils against Staphylococcus aureus].

Authors:  I García; A Pascual; M C Guzmán; E J Perea
Journal:  Enferm Infecc Microbiol Clin       Date:  1991-10       Impact factor: 1.731

3.  Rapid method for the isolation of neutrophils in high yield without the use of dextran or density gradient polymers.

Authors:  P Eggleton; R Gargan; D Fisher
Journal:  J Immunol Methods       Date:  1989-07-06       Impact factor: 2.303

4.  Effects of erythromycin on cellular and humoral immune functions in vitro and in vivo.

Authors:  C E van Rensburg; R Anderson; G Jooné; M van der Merwe; A J van Rensburg
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

5.  Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

6.  Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation.

Authors:  R Anderson
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

7.  Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase.

Authors:  T Watanabe; M Kanno; E Tejima; Y Orikasa
Journal:  Drugs Exp Clin Res       Date:  1992

Review 8.  Macrolides and the immune system.

Authors:  P J McDonald; H Pruul
Journal:  Scand J Infect Dis Suppl       Date:  1992

9.  Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.

Authors:  E M Veringa; J Verhoef
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

10.  Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.

Authors:  A Pascual; G López-López; J Aragón; E J Perea
Journal:  Chemotherapy       Date:  1990       Impact factor: 2.544

View more
  2 in total

Review 1.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 2.  Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review.

Authors:  Suzanne Bongers; Pien Hellebrekers; Luke P H Leenen; Leo Koenderman; Falco Hietbrink
Journal:  Antibiotics (Basel)       Date:  2019-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.